JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1989; 14:1645-1650
© 1989 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Platko, W.
Right arrow Articles by Franco, I
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Platko, W.
Right arrow Articles by Franco, I

Percutaneous transluminal angioplasty of saphenous vein graft stenosis: long-term follow-up

WP Platko, J Hollman, PL Whitlow, and I Franco

Department of Cardiology, Cleveland Clinic Foundation, Ohio 44195-5066.

Percutaneous transluminal angioplasty was used to treat 101 patients with saphenous vein bypass graft stenosis at a mean of 50.1 months (range 2 to 196) after coronary artery bypass surgery. The patients presented between March 1981 and April 1987. A total of 107 saphenous vein grafts were dilated at 117 sites. The primary success rate was 91.8%. The incidence of cardiac complications was 7.1%. There were no cardiac complications in 53 patients with grafts implanted less than 36 months before angioplasty (Group 1). The 48 patients with grafts implanted for greater than 36 months (Group 2) had a 12.5% incidence rate of myocardial infarction, a 4% incidence rate of emergent bypass surgery and a 4% incidence rate of death for an overall cardiac complication rate of 14.9% (p less than 0.01). Follow-up was obtained at a mean of 16.8 +/- 13.9 months (range 1 to 54) in 87 patients (97% of successful cases). Repeat coronary angiography was performed in 49 patients and revealed restenosis in 30 patients (61.2%), with no difference in recurrence rates for proximal, mid or distal graft sites. Clinical recurrence (defined as recurrence of symptoms, myocardial infarction, repeat angioplasty, surgery or death) was 33.1% for Group 1 patients and 64.1% for Group 2 patients (p less than 0.01). The complication and recurrence rates of saphenous vein graft angiography are significantly higher when performed for late (greater than 36 months) vein graft failure. All therapeutic options should be carefully examined before proceeding with angioplasty for saphenous vein graft stenosis in this type of patient.


This article has been cited by other articles:


Home page
CirculationHome page
A. Coolong, D. S. Baim, R. E. Kuntz, A. J. O'Malley, S. Marulkar, D. E. Cutlip, J. J. Popma, and L. Mauri
Saphenous Vein Graft Stenting and Major Adverse Cardiac Events: A Predictive Model Derived From a Pooled Analysis of 3958 Patients
Circulation, February 12, 2008; 117(6): 790 - 797.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Held, P. Tornvall, and U. Stenestrand
Effects of revascularization within 14 days of hospital admission due to acute coronary syndrome on 1-year mortality in patients with previous coronary artery bypass graft surgery
Eur. Heart J., February 1, 2007; 28(3): 316 - 325.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. Ge, I. Iakovou, G. M. Sangiorgi, A. Chieffo, G. Melzi, J. Cosgrave, M. Montorfano, I. Michev, F. Airoldi, M. Carlino, et al.
Treatment of saphenous vein graft lesions with drug-eluting stents: Immediate and midterm outcome
J. Am. Coll. Cardiol., April 5, 2005; 45(7): 989 - 994.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Stankovic, A. Colombo, P. Presbitero, F. van den Branden, L. Inglese, C. Cernigliaro, L. Niccoli, A. L. Bartorelli, P. Rubartelli, N. Reifart, et al.
Randomized Evaluation of Polytetrafluoroethylene-Covered Stent in Saphenous Vein Grafts: The Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial
Circulation, July 8, 2003; 108(1): 37 - 42.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
T M Schiele, E Regar, S Silber, E Eeckhout, D Baumgart, W Wijns, A Colombo, W Rutsch, D Meerkin, A Gershlick, et al.
Clinical and angiographic acute and follow up results of intracoronary {beta} brachytherapy in saphenous vein bypass grafts: a subgroup analysis of the multicentre European registry of intraluminal coronary {beta} brachytherapy (RENO)
Heart, June 1, 2003; 89(6): 640 - 644.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
B. W. Lytle
Coronary Artery Reoperations
Card. Surg. Adult, January 1, 2003; 2(2003): 659 - 679.
[Full Text]


Home page
NEJMHome page
R. Waksman, A. E. Ajani, R. L. White, R. C. Chan, L. F. Satler, K. M. Kent, A. D. Pichard, E. E. Pinnow, A. B. Bui, S. Ramee, et al.
Intravascular Gamma Radiation for In-Stent Restenosis in Saphenous-Vein Bypass Grafts
N. Engl. J. Med., April 18, 2002; 346(16): 1194 - 1199.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. C. Smith Jr, J. T. Dove, A. K. Jacobs, J. Ward Kennedy, D. Kereiakes, M. J. Kern, R. E. Kuntz, J. J. Popma, H. V. Schaff, D. O. Williams, et al.
ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines): A report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions
J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2239 - 2239.
[Full Text] [PDF]


Home page
HeartHome page
U E Heidland, M P Heintzen, C J Michel, and B E Strauer
Risk factors for the development of restenosis following stent implantation of venous bypass grafts
Heart, March 1, 2001; 85(3): 312 - 317.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
B. Bhargava, R. Kornowski, R. Mehran, K. M. Kent, M. K. Hong, A. J. Lansky, R. Waksman, A. D. Pichard, L. F. Satler, and M. B. Leon
Procedural results and intermediate clinical outcomes after multiple saphenous vein graft stenting
J. Am. Coll. Cardiol., February 1, 2000; 35(2): 389 - 397.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. A. Eagle, R. A. Guyton, R. Davidoff, G. A. Ewy, J. Fonger, T. J. Gardner, J. P. Gott, H. C. Herrmann, R. A. Marlow, W. C. Nugent, et al.
ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American Heart Association task force on Practice Guidelines (Committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery)
J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1262 - 1347.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. G. Webb, R. G. Carere, R. Virmani, D. Baim, P. S. Teirstein, P. Whitlow, C. McQueen, F. D. Kolodgie, E. Buller, A. Dodek, et al.
Retrieval and analysis of particulate debris after saphenous vein graft intervention
J. Am. Coll. Cardiol., August 1, 1999; 34(2): 468 - 475.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. E. Abdelmeguid and E. J. Topol
The Myth of the Myocardial `Infarctlet' During Percutaneous Coronary Revascularization Procedures
Circulation, December 15, 1996; 94(12): 3369 - 3375.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
T. Katsumata, M. Endo, K. Ihashi, S. Fujino, H. Nishida, and H. Koyanagi
Post-Stenting Enlarging False Aneurysm of a Saphenous Vein Graft
Ann. Thorac. Surg., October 1, 1995; 60(4): 1121 - 1123.
[Abstract] [Full Text]


Home page
CirculationHome page
J. Lefkovits, D. R. Holmes, R. M. Califf, R. D. Safian, K. Pieper, G. Keeler, E. J. Topol, and f. t. C.-I. Investigators
Predictors and Sequelae of Distal Embolization During Saphenous Vein Graft Intervention From the CAVEAT-II Trial
Circulation, August 15, 1995; 92(4): 734 - 740.
[Abstract] [Full Text]


Home page
CirculationHome page
B. H. Strauss, M. K. Natarajan, W. B. Batchelor, D. E. Yardley, J. A. Bittl, T. A. Sanborn, J. A. Power, L. E. Watson, R. Moothart, J. E. Tcheng, et al.
Early and Late Quantitative Angiographic Results of Vein Graft Lesions Treated by Excimer Laser With Adjunctive Balloon Angioplasty
Circulation, August 1, 1995; 92(3): 348 - 356.
[Abstract] [Full Text]


Home page
CirculationHome page
D. R. Holmes Jr, E. J. Topol, R. M. Califf, L. G. Berdan, F. Leya, P. B. Berger, P. L. Whitlow, R. D. Safian, A. G. Adelman, M. A. Kellett Jr, et al.
A Multicenter, Randomized Trial of Coronary Angioplasty Versus Directional Atherectomy for Patients With Saphenous Vein Bypass Graft Lesions
Circulation, April 1, 1995; 91(7): 1966 - 1974.
[Abstract] [Full Text]


Home page
CirculationHome page
A. Colombo, P. Hall, S. Nakamura, Y. Almagor, L. Maiello, G. Martini, A. Gaglione, S. L. Goldberg, and J. M. Tobis
Intracoronary Stenting Without Anticoagulation Accomplished With Intravascular Ultrasound Guidance
Circulation, March 15, 1995; 91(6): 1676 - 1688.
[Abstract] [Full Text]


Home page
CirculationHome page
S. C. Wong, J. J. Popma, A. D. Pichard, K. M. Kent, L. F. Satler, G. S. Mintz, Y. C. Chuang, M. K. Hong, C. J. Ditrano, and M. B. Leon
Comparison of Clinical and Angiographic Outcomes After Saphenous Vein Graft Angioplasty Using Coronary Versus `Biliary' Tubular Slotted Stents
Circulation, January 15, 1995; 91(2): 339 - 350.
[Abstract] [Full Text]


Home page
NEJMHome page
C. Landau, R. A. Lange, and L. D. Hillis
Percutaneous Transluminal Coronary Angioplasty
N. Engl. J. Med., April 7, 1994; 330(14): 981 - 993.
[Full Text]


Home page
NEJMHome page
J. A. Bittl
Directional Coronary Atherectomy versus Balloon Angioplasty
N. Engl. J. Med., July 22, 1993; 329(4): 273 - 274.
[Full Text]


Home page
ANGIOLOGYHome page
C. Unterberg, A. Buchwald, V. Wiegand, and H. Kreuzer
Coronary Angioplasty in Patients with Previous Coronary Artery Bypass Grafting
Angiology, August 1, 1992; 43(8): 653 - 660.
[Abstract] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1989 by the American College of Cardiology Foundation.